Sequence preferences in the binding to DNA of triostin A and TANDEM as reported by DNase I footprinting  by Low, C.M.Loretta et al.
Volume 176, number 2 FEBS 1922 Gktober 1984 
Sequence preferences in the binding to DNA of triostin A 
and TANDEM as reported by DNase I footprinting 
C.M. Loretta Low, Richard K. Olsentand Michael J. Waring* 
University of Cambridge Department of Pharmacology, Medical School, Hills Road, Cambridge CB2 2QD, England, and 
+Utah State University, Department of Chemistry and Biochemistry, Logan, UT84322, USA 
Received 17 August 1984 
Six or seven triostin-binding sites have been identified in a 160-base-pair DNA restriction fragment contain- 
ing the tyr T promoter sequence. Each is centred round a CpG step, and the minimum binding site-size 
appears to be six base pairs. The sites are practically the same as those reported for echinomycin by DNase 
I digestion. Only two sites are protected by binding of TANDEM, the des-hr-tetramethyl analogue of trios- 
tin A; they are centred around the sequences ATA or TAT. 
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1. INTRODUCTION 
Quinoxaline antitumour antibiotics are pro- 
duced by a variety of streptomycetes. They are 
characterised by a cross-bridged octadepsipeptide 
ring to which are attached two moieties of 
quinoxaline-2-carboxylic acid [ 1,2]. Depending 
upon the exact constitution of that cross-bridge, 
the antibiotics fall into two families called 
quinomycins and triostins, the former having a 
thioacetal cross-bridge and the latter a disulphide. 
The representative member of the quinomycins is 
echinomycin and that of the triostins is triostin A 
(fig.la). All these antibiotics have been shown to 
bind strongly to double-stranded DNA by a 
whanism. of bifunctional intercalation [3,4]. 
Equilibrium binding studies have established 
that echinomycin and triostin A bind better to 
natural DNAs which are rich in G+ C residues, 
although in general triostin A appears to display 
somewhat less pronounced sequence selectivity 
[5-71. Moreover, triostin A binds more tightly to 
poly(dA-dT) than to poly(dG-dC) whereas the 
reverse is true for echinomycin. These results sug- 
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gest that here are subtle differences in the precise 
base sequence preferences of the two antibiotics. 
We have previously reported sequence selectivity 
of echinomycin as revealed by DNase I footprin- 
ting of a l&base-pair DNA fragment from 
Escherichia coli containing the tyr T promoter se- 
quence [8]. A similar study using MPE - Fe (II) 
footprinting has also been published [9]. The bin- 
ding sites were all found to contain the 
dinucleotide sequence CpG. Here, we describe the 
results of similar experiments to investigate the 
preferred binding sequence(s) of triostin A. 
Unlike the naturally occurring quinoxaline an- 
tibiotics, the synthetic des-ZV-tetramethyl analogue 
of triostin A nicknamed TANDEM (fig.lb) 
displays a strong preference for binding to AT-rich 
DNAs, the extreme manifestation of which is seen 
with poly(dA-dT) to which it binds at least 5000 
times more tightly than to poly(dG-dC) [3, lo]. We 
demonstrate here that the preferred binding sites 
for TANDEM in our DNA fragment, revealed via 
blockages of DNase I digestion, contain alter- 
nating A and T residues. Thus in this case the se- 
quence selectivity deduced from observations with 
synthetic polynucleotides applies to natural DNA 
species as well. 
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Fig.1. (a) Structure of triostin A. (b) Structure of TANDEM. 
2. MATERIALS AND METHODS 
Triostin A was a gift from Drs H. Otsuka and T. 
Yoshida of Shionogi and Co., Osaka, Japan. 
TANDEM was synthesised, characterised and 
purified as in Ill]. Concentrations were deter- 
mined s~ctrophotometrically from the absorbance 
at 325 nm using extinction coefficients of 
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10 900 M-r-cm-” and 12 130 M-r *cm-’ for 
triostin A and TANDEM, respectively [3,5]. Stock 
solutions of each ligand were prepared in a 
methanol-buffer mixture (40: 60, v/v) because of 
their low aqueous solubility. The buffer used was 
10 mM Tris-HCI, pH 7.5, containing 10 mM 
NaCl. The final concentration of rn~ha~ol present 
in the digestion mixture did not exceed 20%. Con- 
trols were performed as before [8] to verify that the 
presence of methanol did not interfere with the en- 
zyme action. 
Deoxyribonuclease I (DNase I) was obtained 
from Sigma and prepared as a 7200 units/ml stock 
solution in 0.15 M NaCl containing 1 mM MgC12. 
It was stored at -20°C and diluted to working 
concentration imme~ately before use. The diges- 
tion buffer used for dilution contained 20 mM 
NaCl, 2 mM MgCl2 and 2 mM MnC12. 
A 160-base-pair duplex DNA fragment from E. 
coli, containing the tyrosine tRNA promoter 
together with its adjacent sequences, was a gift 
from Drs A.A. Travers and H.R. Drew. Its 
nucleotide sequence is represented in fig.3. The up- 
per sequence (‘Watson strand’, reading 5 ’ -3 ’ 
from left to right) can be labelled at the AvaI site 
at its 3 ‘-end with [ar-32P]dCTP and the lower se- 
quence (‘Crick strand’, reading 5 ‘-3’ from right 
to left) can be labelled at the EcoRI site at its 
3 ‘-end with [a-3zP]dATP. 3 ‘-End labelling was 
performed as in 18,121. An aliquot (3~1) of the 
labelled DNA (9 pmol in base pairs) was incubated 
with 5 /11 triostin A (5-20rM) or TANDEM 
(15-4OpM) at 37°C for 30 min, then digested with 
2 ~1 DNase I (final concentration 0.05 units/ml). 
Samples (3 ~1) were removed from the mixture 
after 1, 5 and 30 min digestion and the reaction 
stopped by adding 2.5 /cl of 80% formamide solu- 
tion containing 0.1% bromophenol blue and 
10 mM EDTA, They were heated at 100°C for at 
least 2 min prior to electrophoresis IS]. 
3. RESULTS 
3.1. Tr~o~~i~ A 
Patterns of DNase I digestion for the Watson 
and Crick strands of the 160-base-pair DNA frag- 
ment in the presence of triostin A are shown in 
fig&b, respectively. Six major binding sites are 
apparent, located around positions 20,58,73,76, 
100 and IO7 on both strands. A seventh site may be 
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Fig.2. DNase I footp~ntiug of triostin A on a 160-base- 
pair DNA fragment from E. coli. Symbols W*C and 
WC* indicate which of the two strands (Watson or 
Crick) bears a radioactive 3’-end label. Time in minutes 
(I,& 30) after the addition of enzyme is shown at the top 
of each gel lane. The extent of digestion was limited to 
2040% of the starting material so as to minimise the 
incidence of multiple cuts in any strand. Tracks labelled 
‘G’ are dimethyl sulphate-piperidine marker lanes 
specific for guanine. Numbers on the left refer to the 
nurn~~ng scheme shown in fig.3, while sites of 
protection from DNase I digestion are identified on the 
right. 
discerned from the gap in the Crick strand near 
position 140 at the top of fig.Zb. The minimum 
binding site-size appears to be 6 base pairs, as can 
be seen from the blockage at positions 54-60 in 
fig.2b. The broad protected zone around position 
105 seems in fact to contain two closely spaced 
sites of blockage, as is evident from fig.2a. No in- 
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termediate states of ~tibiotic-induct protection the 3’-end, as noted in previous studies with other 
from cleavage were apparent at varying triostin ligands [8,12-141. At ‘site 2’, for example, protec- 
concentrations. Little or no protection was ob- tion extends from positions 56 to 62 on the Watson 
served at antibiotic concen~ations below 5 FM strand, and from positions 54 to 60 on the Crick 
while no further protection was afforded above strand. The cross-strand stagger in the regions sub- 
10 pM. ject to enhanced cleavage is less obvious. 
All 7 binding sites are associated with one or 
more steps of the dinucleotide sequence CpG 
(fig.3). The only such step that is not strongly pro- 
tected is the one at position 35. In general, these 
f~tprints produced by triostin A are broadly 
similar to those observed with echinomycin [8], 
although the blockages are less pronounced. 
Enhanced cleavage relative to that in the control 
occurs at flanking sequences adjacent to certain 
binding sites, notably at positions 30, 50, 65 and 
130. These areas contain long runs of A and T, for 
example, ATTTTTCT around position 50 and 
AAAAAG at position 130. By contrast, there is no 
effect on the rate of cleavage at the GC-rich 
regions adjacent to binding sites 5 and 6. 
3.2. TANDEM 
The DNase I digestion pattern for bonds 75-120 
of the Watson strand in the presence of this ligand 
is shown in fig.4. Two binding sites can be dis- 
cerned from the footprints, located near positions 
88 and 110. They are each about 8 base pairs in 
length. No other protected regions could be seen. 
Parallel experiments on the Crick strand (gel not 
shown) revealed that the binding sites were again 
staggered by two base pairs towards the 3 ’ end 
(fig.3). No protection was observed below 15 ,uM 
TANDEM and no further protection beyond 
30 FM. 
The protected zones measured on the two 
strands appear to be staggered two bonds towards 
The DNase I digestion patterns observed in the 
presence of TANDEM are clearly very different 
from those seen in the presence of triostin A and 
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Fig.3. Summary of footprinting results for triostin A (unfilled bars, open triangles) and TANDEM (filled bars, filled 
triangles). Bars indicate protected regions while triangles how positions of enhanced cutting. The upper sequence 
represents he ‘Watson’ (antisense) strand and the lower sequence the ‘Crick’ (sense, coding) strand. These maps were 
compiled from visual inspection of numerous gels as well as from densitometric tracings, and may be considered as a 
set of averaged values. Note that the increased sensitivity to DNase I in the presence of TANDEM is much less 
pronounced than that seen with triostin A. 
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Fig.4. DNase I footprinting of TANDEM on the 
160-base-pair DNA fragment with Watson strand 
bearing aradioactive 3’-end label. Labelling as in fig.2. 
ecbinomycin, and the binding sites appear to be 
centred around the sequences ATAT and ATAA. 
The protection afforded by TANDEM is very 
much weaker, as expected since its binding cons- 
tant for natural DNAs is known to be about 
2@-fold lower than that of echinomycin or of 
triostin A [2,3]. The binding of TANDEM appears 
to be rather specific, since not all AT-rich se- 
quences are protected. 
Enhancement of enzymatic cleavage at se- 
quences flanking the binding sites can again be 
observed, especially on the Watson strand, 
although the phenomenon is very much less pro- 
noun&. The most prominent effect occurs bet- 
ween positions 78-8 1. 
4. DISCUSSION 
4.1, Triostin A 
The DNase I protection patterns reveal that all 
the triostin A binding sites contain the dinucleotide 
step CpG. However, the sequence ACGC at posi- 
tion 35 is only weakly protected, in contrast with 
the same sequence at position 78. Perhaps the jux- 
taposition, in this case, of the CpG ~nucleotide 
beside the long AT-rich region from positions 
27-34 somehow hinders its interaction with the an- 
tibiotic. It is also difficult to determine whether 
CpG at position 95 is truly protected or not since 
it is only included in the blockage site on the Crick 
strand but not the Watson strand of the DNA. 
The footprinting patterns obtained for triostin A 
do not differ si~~c~tly from those obtained 
with echinomycin, [&I. As with echinomycin, the 
preferred binding sequence can be deduced to be 
XCGY, where X,Y are either purine or pyrimidine. 
The similarity of the footprints for the two an- 
tibiotics is surprising since their relative binding af- 
finities for poly(dA-dT) and poly(dG-dC) are quite 
different, implying definite differences in the 
precise base sequence(s) of their preferred binding 
site(s) 151. However, these polynucleotides may 
adopt different helical structures as compared to 
natural DNAs [15,16], so that binding data ob- 
tained with them may tend to exaggerate small dif- 
ferences in the intrinsic sequence preferences of the 
antibiotics. It may therefore be advisable to assess 
the footprinting patterns in the light of equilibrium 
binding data for natural DNAs. The equilib~um 
binding experiments reported several years ago 
showed that echinomycin and triostin A bind to 
various natural DNAs in much the same ranking 
order, ~thou~h triostin A displays a smaller 
overall variation in binding constants than does 
echinomycin [7]. 
4.2. TANDEM 
The preferred binding sites of TANDEM are 
clearly different from those of triostin A or 
echinomycin. The regions blocked do not contain 
the step CpG but rather are centred around the se- 
quences ATA or TAT. This is perfectly consistent 
with equilibrium binding studies which revealed 
418 
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that TANDEM binds best to those DNAs which 
are rich in AT residues [3]. The structure of 
TANDEM [17] is such as to predict that when it 
binds to double-helical DNA two base pairs are 
sandwiched between the quinoxaline chromo- 
phores in the b&intercalated complex. Unfor- 
tunately, the present data are not sufficient to 
determine unambiguously whether the sandwiched 
base sequence is ApT or TpA, nor whether par- 
ticular sequences are required in the flanking 
regions. It appears that structural differences must 
play a significant part in determining those ApT 
(or TpA) steps that will or will not bind the ligand. 
Most probably these dinucleotides will not provide 
TANDEM binding sites if they are either preceded 
or followed by runs of A or T. For example the 
ApT at position 31 is preceded by the sequence 
GA&A while that at position 47 is followed by 
TTTTCT: neither site is protected from DNase 
digestion by TANDEM. It has been suggested that 
runs of A and T possess a peculiar helical structure 
[12,18-201, and this may set up long-range 
changes affecting the ability of nearby ApT (or 
TpA) sequences to interact with the ligand. 
Nevertheless, our experimental findings as sum- 
marised in fig.3 permit two further observations. 
If we assume that ApT is the sandwiched 
dinucleotide sequence, as suggested from the 
crystal structure of TANDEM [17], then it is 
noticeable that in both binding sites one of the 
flanking bases is A or T, continuing the alternating 
purine-pyrimidine sequence, while the other base 
can be G or C. On the other hand, it has been 
reported that poly d(TAC) - poly d(GTA) binds 
TANDEM while poly d(ATC) - poly d(GAT) does 
not, suggesting that the ligand recognises TpA 
rather than ApT sequences [21]. If this interpreta- 
tion is correct, the preferred sequence appears to 
be XTAY where X and Y can be either A or T. 
4.3. Enhancement of susceptibility to nuclease 
attack 
The increases in cleavage rate at certain se- 
quences observed in the presence of triostin A are 
similar to those seen with echinomycin [8], and oc- 
cur at AT-rich regions adjacent to the binding 
sites. With TANDEM there is a very slight 
enhancement of cleavage at flanking GC-rich 
regions, observed mainly on the Watson strand. 
A crystalline complex between triostin A and the 
hexanucleotide CGTACG has been described in 
which the TA step is a Hoogsteen base pair [22]. 
However, we do not consider it likely that the 
enhancement of cleavage at AT sequences ob- 
served here results from drug-induced Hoogsteen 
base-pairing for two reasons. Firstly, chemical 
reactions using dimethyl sulphate and bromo- 
acetaldehyde have failed to detect any Hoogsteen 
pairings (H.R. Drew, personal communication). 
Secondly, similar enhancements are also produced 
by elevated temperature and dimethyl sulphoxide 
[12]. Hence the enhanced cleavages een here are 
more likely to reflect some local helical distortion, 
caused by unwinding of adjacent regions of DNA 
by intercalation of the antibiotic [7]. It may well 
prove to be a general property of sequence-specific 
intercalators that they cause enhancement of en- 
zymic cleavage at certain regions flanking their 
binding sites. 
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